Institution
7 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 9, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 trial registration with no results posted; study is actively recruiting and designed to assess efficacy and safety of tirzepatide in binge-eating disorder.
This is a Phase 1 registry record with no posted results; it describes a planned single-dose interventional study in a small sample (n=40) using surrogate endpoints (affect, pain catastrophizing, quantitative sensory testing) to explore mechanistic effects of psilocybin in a novel indication.
SEP 4, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a Phase 2 trial registration with no results posted; the study is not yet recruiting and therefore carries no outcome data to evaluate.
SEP 4, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is an ongoing observational registry study with no results reported; it aims to establish an association between blood-brain barrier disruption and post-stroke cognitive decline over 3 years.
SEP 4, 2026 · PHASE EARLY PHASE 1 TRIAL
ClinicalTrials.gov
Early-phase pilot study with no results yet reported; designed to assess safety and feasibility of psilocybin in a cognitively vulnerable population.
AUG 11, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a terminated registry record with no reported results; only 9 participants were enrolled in an uncontrolled behavioral intervention pilot, making it a feasibility study without outcome data.
AUG 6, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a completed trial registration with no results posted; the study design and planned outcomes are documented but effectiveness data are not reported in this registry record.